Oh, Bong Kyun
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
Studies examining body composition changes during GLP-1 therapy, including the STEP trials (semaglutide) and SURMOUNT-1 (tirzepatide), have demonstrated that approximately 2540% of total weight lost may come from lean body mass, including skeletal muscle, rather than exclusively from fat mass
Fatty foods require more time and digestive effort to process, and when combined with semaglutide's gastric-slowing effects, they may sit uncomfortably in the stomach for extended periods
When youre nauseous, you dont eat, so not only are we restricting because we dont feel good, but then were also purging the food that is in our system because were nauseous, Ross-Nash said
